LISATA THERAPEUTICS INC (LSTA:NASDAQ)
$1.64 -0.26 (-13.6842%)
Analysed LISATA THERAPEUTICS INC (LSTA:NASDAQ) News Sources
How The Evolving Story For Lisata Therapeutics (LSTA) Is Reshaping Its Valuation Outlook
22-01-2026
yahoo.com
Lisata Therapeutics And 2 Other Penny Stocks Worth Watching
22-01-2026
yahoo.com
Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide
27-01-2026
yahoo.com
Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
06-03-2026
yahoo.com
Lisata Therapeutics shares up 20% as Kuva Labs acquisition advances
09-03-2026
proactiveinvestors.com
Sector Update: Healthcare Stocks Higher Late Afternoon
24-07-2026
yahoo.com
Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc.
10-06-2026
yahoo.com
Lisata Therapeutics agrees to Kuva Labs buyout at $4 per share
10-06-2026
proactiveinvestors.com
Lisata Therapeutics Provides Update Following Termination of Merger Agreement
04-08-2026
yahoo.com
Lisata Therapeutics moves forward with legal action following Kuva merger termination
04-08-2026
proactiveinvestors.com
What is the current price of LISATA THERAPEUTICS INC (LSTA:NASDAQ)?
The current price of LISATA THERAPEUTICS INC (LSTA:NASDAQ) is $1.64.
LISATA THERAPEUTICS INC (LSTA:NASDAQ) absolute price change since previous trading day?
The absolute price change of LISATA THERAPEUTICS INC (LSTA:NASDAQ) since the previous trading day is $-0.26.
LISATA THERAPEUTICS INC (LSTA:NASDAQ) percentage price change since previous trading day?
The percentage price change of LISATA THERAPEUTICS INC (LSTA:NASDAQ) since the previous trading day is -13.6842%.
What is the most recent average sentiment score for LISATA THERAPEUTICS INC (LSTA:NASDAQ)?
The most recent average sentiment score for LISATA THERAPEUTICS INC (LSTA:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for LISATA THERAPEUTICS INC (LSTA:NASDAQ)?
The most recent sentiment for LISATA THERAPEUTICS INC (LSTA:NASDAQ) is .
SEC-8K** Filing Available For LISATA THERAPEUTICS INC (LSTA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.